Literature DB >> 15644497

Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels.

Mauro Federici1, Raffaella Geracitano, Alessandro Tozzi, Patrizia Longone, Silvia Di Angelantonio, C Peter Bengtson, Giorgio Bernardi, Nicola B Mercuri.   

Abstract

Trace amines (TAs) are present in the central nervous system in which they up-regulate catecholamine release and are implicated in the pathogenesis of addiction, attention-deficit/hyper-activity disorder, Parkinson's disease, and schizophrenia. By using intracellular and patch-clamp recordings from dopaminergic cells in the rat midbrain slices, we report a depressant postsynaptic action of two TAs, beta-phenylethylamine (beta-PEA) and tyramine (TYR) on the GABA(B)-mediated slow inhibitory postsynaptic potential and baclofen-activated outward currents. beta-PEA and TYR activated G-proteins, interfering with the coupling between GABA(B) receptors and G-betagamma-gated inwardly rectifying potassium channels. This is the first demonstration that beta-PEA and TYR depress inhibitory synaptic potentials in neurons of the central nervous system, supporting their emerging role as neuromodulators.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15644497     DOI: 10.1124/mol.104.007427

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

Review 1.  Trace amine-associated receptors and their ligands.

Authors:  R Zucchi; G Chiellini; T S Scanlan; D K Grandy
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

2.  Gamma-aminobutyric acid inhibits synergistic interleukin-6 release but not transcriptional activation in astrocytoma cells.

Authors:  Joseph D Roach; Grant T Aguinaldo; Kaumudi Jonnalagadda; Francis M Hughes; Bryan L Spangelo
Journal:  Neuroimmunomodulation       Date:  2008-08-05       Impact factor: 2.492

3.  Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells.

Authors:  Ada Ledonne; Mauro Federici; Michela Giustizieri; Mauro Pessia; Paola Imbrici; Mark J Millan; Giorgio Bernardi; Nicola B Mercuri
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Tyramine excites rat subthalamic neurons in vitro by a dopamine-dependent mechanism.

Authors:  Zi-Tao Zhu; Adam C Munhall; Steven W Johnson
Journal:  Neuropharmacology       Date:  2006-12-28       Impact factor: 5.250

5.  Down-regulated GABAergic expression in the olfactory bulb layers of the mouse deficient in monoamine oxidase B and administered with amphetamine.

Authors:  Hsiang-Shu Yin; Kevin Chen; Jean C Shih; Tai-Wei Tien
Journal:  Cell Mol Neurobiol       Date:  2009-11-10       Impact factor: 5.046

Review 6.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

7.  The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.

Authors:  Amyaouch Bradaia; Gerhard Trube; Henri Stalder; Roger D Norcross; Laurence Ozmen; Joseph G Wettstein; Audrée Pinard; Danièle Buchy; Martin Gassmann; Marius C Hoener; Bernhard Bettler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

8.  Electrophysiological effects of trace amines on mesencephalic dopaminergic neurons.

Authors:  Ada Ledonne; Nicola Berretta; Alessandro Davoli; Giada Ricciardo Rizzo; Giorgio Bernardi; Nicola Biagio Mercuri
Journal:  Front Syst Neurosci       Date:  2011-07-04

9.  Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function.

Authors:  Xiao Shi; Nicole A R Walter; John H Harkness; Kim A Neve; Robert W Williams; Lu Lu; John K Belknap; Amy J Eshleman; Tamara J Phillips; Aaron Janowsky
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

Review 10.  Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.

Authors:  Yue Pei; Aman Asif-Malik; Juan J Canales
Journal:  Front Neurosci       Date:  2016-04-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.